Trial · NCT07895082
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Change in bone mineral density (BMD) of the lumbar spine (L1-L4) | Baseline and 6 months | BMD of the lumbar spine (L1-L4) measured by dual-energy X-ray absorptiometry (DXA). The absolute change and percentage change from baseline will be calculated. |
| Secondary | Change in Serum Calcium | Baseline and 6 months | Serum calcium measured by laboratory tests. Change from baseline will be calculated. |
| Secondary | Change in Serum Phosphorus | Baseline and 6 months | Serum phosphorus measured by laboratory tests. Change from baseline will be calculated. |
| Secondary | Change in muscle strength | Baseline and 6 months | Muscle strength is assessed by study-specific measurements during the study. |
| Secondary | Change in incidence of falls | Baseline and 6 months | the number and incidence of falls should be recorded during the study. |
| Secondary | Change in 25-Hydroxyvitamin D | Baseline and 6 months | Serum 25-hydroxyvitamin D measured by laboratory tests. Change from baseline will be calculated. |
| Secondary | Change in Parathyroid Hormone (PTH) | Baseline and 6 months | Serum parathyroid hormone (PTH) measured by laboratory tests. Change from baseline will be calculated. |
| Secondary | Change in Serum P1NP | Baseline and 6 months | Serum procollagen type 1 N-terminal propeptide (P1NP), a bone formation marker, measured by laboratory tests. Change from baseline will be calculated. |
| Secondary | Change in Serum CTX | Baseline and 6 months | Serum C-terminal telopeptide of type I collagen (CTX), a bone resorption marker, measured by laboratory tests. Change from baseline will be calculated. |
| Secondary | Change in Serum Osteocalcin | Baseline and 6 months | Serum osteocalcin measured by laboratory tests. Change from baseline will be calculated. |
| Secondary | Change in Bone Mineral Density (BMD) of the Femoral Neck and Total Hip | Baseline and 6 months | BMD of the femoral neck and total hip measured by dual-energy X-ray absorptiometry (DXA). Change from baseline will be calculated for each site. |
| Secondary | Change in T-score at the Femoral Neck and Total Hip | Baseline and 6 months | T-score at the femoral neck and total hip measured by DXA. Change from baseline will be calculated for each site. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT07895082/registered